In conclusion, the findings of our study, comprising a combined cohort of over 38 million individuals with T2DM and controls, suggest that the use of GLP-1 RAs is not associated with an increased risk of cancers, including pancreatic cancer and MTC, compared with the use of other antidiabetic drugs
Consider a study presented at ENDO 2024, which is the Endocrine Societys annual meeting that was held in guess what year 2024
[DOI] [PubMed] [Google Scholar] 69.Masarwa R., Brunetti V.C., Aloe S., Henderson M., Platt R.W., Filion K.B
With continued use, skin tone appears more even, clearer, and full of moisture
Breau M, Houssaini A, Lipskaia L, Abid S, Born E, Marcos E, Czibik G, Attwe A, Beaulieu D, Palazzo A, Flaman JM, Bourachot B, Collin G, Tran Van Nhieu J, Bernard My, Mechta-Grigoriou F, Adnot S